By Sangeeta Shashikant, TWN Info Service on WTO and Trade Issues
Intense and rushed formal and informal consultations have been taking place since last Friday 2 December to find agreement among WTO Members on the content of an amendment to the TRIPS Agreement, which is to constitute a 'permanent solution' for facilitating the supply of medicines to countries with insufficient or no drug manufacturing capacity.
With the Doha global trade talks stalled by US and European discord over agriculture, US lawmakers are warning that domestic political support for the round could be jeopardised if the Hong Kong ministerial meeting next week focuses exclusively on the narrow demands from a few developing countries
By Kanaga Raja (SUNS), TWN Info Service on WTO and Trade Issues
The WTO General Council late Tuesday 6 December approved an amendment to the TRIPS Agreement making permanent a decision originally adopted in 2003 to resolve the problem of supply of generic versions of pharmaceutical products to countries with inadequate manufacturing capacity, due to limitations in the TRIPS Agreement when using compulsory license.